Diastolic balloon pumping (with carbon dioxide) in the aorta—A mechanical assistance to the failing circulation

Moulopoulos, Spyridon D.; Topaz, Stephen R.; Kolff, Willem J.

doi:10.1016/0002-8703(62)90012-1

Cited by 441 publications

(125 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…IABP was developed in 1962, 7 and clinical use of this device was first reported in 1968. 8 Percutaneous insertion was described by Bregman et al in 1980, allowing for widespread use.…”

Section: Discussionmentioning

confidence: 99%

Clinical Implications of Thrombocytopenia Among Patients Undergoing Intra‐aortic Balloon Pump Counterpulsation in the Coronary Care Unit

Roy

Howard

Panza

et al. 2010

Clinical Cardiology

View full text Add to dashboard Cite

Background: Thrombocytopenia Hypothesis: intra-aortic balloon pump (IABP)-associated thrombocytopenia is not associated with an increased risk of major bleeding or in-hospital death. Thrombocytopenia is a common adverse effect of the IABP. However, the clinical implications of IABP-associated thrombocytopenia are unknown. Methods: We assessed the incidence and predictors of thrombocytopenia, and the association between thrombocytopenia and relevant clinical end points, using prospectively collected data on 252 consecutive patients undergoing IABP in a single coronary care unit (CCU). Results: Anticoagulation with intravenous heparin was administered to 182 patients (72%). Baseline platelet counts were 232 000 ± 96 000 mL, decreased to 154 000 ± 74 000 mL at day 3, and recovered to baseline by day 8. Thrombocytopenia (nadir <150 000 mL or >50% reduction from baseline) occurred in 109 patients (43%), with a similar incidence among patients who received heparin and those who did not (45% vs 40%, P = 0.5). Independent predictors of thrombocytopenia were lower body weight, cardiogenic shock, and duration of IABP support. The incidence of both major bleeding and in-hospital death were higher among patients who developed thrombocytopenia than among those who did not (13.8% vs 4.2%, P = 0.01 and 28% vs 16%, P = 0.02, respectively). However, after controlling for confounding variables, thrombocytopenia was not an independent predictor of either major bleeding (odds ratio [OR]: 2.2, 95% confidence interval [CI]: 0.8-6.4, P = 0.1) or in-hospital death (OR: 1.5, 95% CI: 0.8-2.9, P = 0.3). Conclusions: Among patients undergoing IABP in the CCU, thrombocytopenia is generally mild, appears to be unrelated to concomitant heparin use, and is not associated with an increased risk of major bleeding or in-hospital death.

show abstract

“…IABP was developed in 1962, 7 and clinical use of this device was first reported in 1968. 8 Percutaneous insertion was described by Bregman et al in 1980, allowing for widespread use.…”

Section: Discussionmentioning

confidence: 99%

Clinical Implications of Thrombocytopenia Among Patients Undergoing Intra‐aortic Balloon Pump Counterpulsation in the Coronary Care Unit

Roy

Howard

Panza

et al. 2010

Clinical Cardiology

View full text Add to dashboard Cite

show abstract

“…Bir yıl sonra Moulopoulos ve ekibi şişebilen lateks bir balon yapmışlar. Bu balonun EKG ile senkronize olarak şişip sönmesi ile sistol başındaki arteriyel basınç düşürülmüş ve diyastolik basınç arttırılmıştı [6]. Daha sonra De-Bakey bu fikri modifiye etmiş, sol atriyo-aortik baypas ve kardiyopulmoner baypassdan ayrılamayan hastalarda pompaya implante edilen apereyle başarıyla kullanılmıştır.…”

Section: İabp Tarihçesiunclassified

Useage of Intra-aortic Baloon Pump in the Open Heart Surgeries [Acik Kalp Ameliyatlarinda Intra-Aortik Balon Pompasi Kullanilmasi]

Ozdemir¹,

Yener²,

Saçar³

2015

Med-Science

View full text Add to dashboard Cite

show abstract

“…In 1962, Moulopoulos et al 2 , using the counter pulsation principle, developed the modern intra-aortic balloon pump (IABP), which consisted of a flask mounted on a flexible two-lumen catheter that was able to inflate and deflate in the descending thoracic aorta during each cardiac cycle.…”

Section: Introductionmentioning

confidence: 99%

Intra-aortic balloon pump in cardiogenic shock: state of the art

Thomaz¹,

Júnior²,

Muramoto

et al. 2017

Rev. Col. Bras. Cir.

View full text Add to dashboard Cite

The clinical definition of cardiogenic shock is that of a low cardiac output and evidence of tissue hypoxia in the presence of adequate blood volume. Cardiogenic shock is the main cause of death related to acute myocardial infarction (AMI), with a mortality rate of 45-70% in the absence of aggressive and highly specialized technical care. The intra-aortic balloon pump (IABP) is one of the most widely used mechanical assisting devices. During the last two decades, about 42% of patients with AMI who evolved with cardiogenic shock received mechanical circulatory assistance with IABP. Its clinical indication has been based on non-randomized studies and registry data. Recent studies have shown that the use of IABP did not reduce 30-day mortality in patients with AMI and cardiogenic shock treated with the strategy of early myocardial revascularization as the planned primary objective. The guidelines of the American Heart Association and of the European Society of Cardiology have reassessed their recommendations based on the results of meta-analyzes, including the IABP-SCHOCK II Trial study, which did not evidence an increase in survival of patients who received mechanical support with IABP. This review article addresses the clinical impact of IABP use in the cardiogenic shock caused by AMI.

show abstract

Diastolic balloon pumping (with carbon dioxide) in the aorta—A mechanical assistance to the failing circulation

Cited by 441 publications

References 4 publications

Clinical Implications of Thrombocytopenia Among Patients Undergoing Intra‐aortic Balloon Pump Counterpulsation in the Coronary Care Unit

Clinical Implications of Thrombocytopenia Among Patients Undergoing Intra‐aortic Balloon Pump Counterpulsation in the Coronary Care Unit

Useage of Intra-aortic Baloon Pump in the Open Heart Surgeries [Acik Kalp Ameliyatlarinda Intra-Aortik Balon Pompasi Kullanilmasi]

Intra-aortic balloon pump in cardiogenic shock: state of the art

Contact Info

Product

Resources

About